Results of the home mechanical ventilation national program among adults in Chile between 2008 and 2017.
Chronic respiratory failure
Domiciliary ventilation
Home mechanical ventilation
Long term ventilation
Obesity hypoventilation syndrome
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
02 Dec 2021
02 Dec 2021
Historique:
received:
14
06
2021
accepted:
23
11
2021
entrez:
3
12
2021
pubmed:
4
12
2021
medline:
15
3
2022
Statut:
epublish
Résumé
Home mechanical ventilation (HMV) is a viable and effective strategy for patients with chronic respiratory failure (CRF). The Chilean Ministry of Health started a program for adults in 2008. This study examined the following data from a prospective cohort of patients with CRF admitted to the national HMV program: characteristics, mode of admission, quality of life, time in the program and survival. A total of 1105 patients were included. The median age was 59 years (44-58). Women accounted for 58.1% of the sample. The average body mass index (BMI) was 34.9 (26-46) kg/m The most common diagnoses were COPD and OHS. The best survival was observed in patients with OHS, scoliosis and NMD. The SRI score improved significantly in the follow-up of patients with HMV. The prevalence of HMV was 10.4 per 100,000 inhabitants. Trial registration This study was approved by and registered at the ethics committee of North Metropolitan Health Service of Santiago, Chile (N° 018/2021).
Sections du résumé
BACKGROUND
BACKGROUND
Home mechanical ventilation (HMV) is a viable and effective strategy for patients with chronic respiratory failure (CRF). The Chilean Ministry of Health started a program for adults in 2008.
METHODS
METHODS
This study examined the following data from a prospective cohort of patients with CRF admitted to the national HMV program: characteristics, mode of admission, quality of life, time in the program and survival.
RESULTS
RESULTS
A total of 1105 patients were included. The median age was 59 years (44-58). Women accounted for 58.1% of the sample. The average body mass index (BMI) was 34.9 (26-46) kg/m
CONCLUSION
CONCLUSIONS
The most common diagnoses were COPD and OHS. The best survival was observed in patients with OHS, scoliosis and NMD. The SRI score improved significantly in the follow-up of patients with HMV. The prevalence of HMV was 10.4 per 100,000 inhabitants. Trial registration This study was approved by and registered at the ethics committee of North Metropolitan Health Service of Santiago, Chile (N° 018/2021).
Identifiants
pubmed: 34856963
doi: 10.1186/s12890-021-01764-4
pii: 10.1186/s12890-021-01764-4
pmc: PMC8641152
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
394Informations de copyright
© 2021. The Author(s).
Références
Am J Respir Crit Care Med. 2015 Jul 1;192(1):86-95
pubmed: 25915102
Neuromuscul Disord. 2002 Dec;12(10):926-9
pubmed: 12467747
Chest. 2007 Jun;131(6):1650-8
pubmed: 17565016
J Clin Epidemiol. 2003 Aug;56(8):752-9
pubmed: 12954467
Respir Med. 2007 Jun;101(6):1074-8
pubmed: 17118638
Respirology. 2019 Jun;24(6):521-530
pubmed: 30912216
Eur Respir J. 2005 Jun;25(6):1025-31
pubmed: 15929957
Cochrane Database Syst Rev. 2014 Dec 13;(12):CD001941
pubmed: 25503955
Am Rev Respir Dis. 1976 May;113(5):587-600
pubmed: 1267262
Respiration. 2018;96(5):446-454
pubmed: 30007983
Respiration. 2015;89(4):312-21
pubmed: 25791249
Eur Respir J. 2013 Jan;41(1):39-45
pubmed: 22653765
Respir Care. 2015 May;60(5):695-704
pubmed: 25587173
J Fam Pract. 1982 Aug;15(2):303-11
pubmed: 7097168
Respir Med. 2020 Feb;162:105877
pubmed: 32056675
BMC Pulm Med. 2020 Aug 17;20(1):221
pubmed: 32807149
Chest. 2020 Jul;158(1):279-291
pubmed: 32243941
Chest. 1999 Aug;116(2):521-34
pubmed: 10453883
Arch Bronconeumol. 2006 Nov;42(11):588-93
pubmed: 17125694
J Fam Pract. 1978 Jun;6(6):1231-9
pubmed: 660126
BMC Med Res Methodol. 2004 Jun 17;4:15
pubmed: 15202950
Lancet Neurol. 2006 Feb;5(2):140-7
pubmed: 16426990
Lancet Respir Med. 2014 Sep;2(9):698-705
pubmed: 25066329
Chest. 2003 Jan;123(1):67-79
pubmed: 12527605
Respir Care. 2018 Apr;63(4):380-387
pubmed: 29208755